EV/EBITDA
-17.70
+0.87+4.68%
1 min ago
Summary
- As of February 7, 2025, APLS EV/EBITDA is -17.70, with a rise of +0.87 (+4.68%) during the most recent trading day.
- Over the past year, APLS EV/EBITDA has dropped by -2.08 (-13.32%).
- APLS EV/EBITDA is now -393.04% below its all-time high of -3.59.
Performance
APLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APLS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +4.7% | -4.7% | -4.8% |
| 1 m1 month | +12.3% | -12.3% | -12.5% |
| 3 m3 months | -1.3% | +1.3% | +1.3% |
| 6 m6 months | -25.9% | -11.5% | -12.7% |
| ytdytd | +10.2% | -10.2% | -10.4% |
| 1 y1 year | -13.3% | -52.0% | -56.1% |
| 5 y5 years | -77.5% | +24.6% | -31.0% |
APLS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.0% | -20.93 | +15.4% | |
| 3 m | 3-month | -16.10 | -9.9% | -21.58 | +18.0% |
| 6 m | 6-month | -12.45 | -42.2% | -21.58 | +18.0% |
| 1 y | 1-year | -11.35 | -56.0% | -21.58 | +18.0% |
| 3 y | 3-year | -3.59 | -393.0% | -21.58 | +18.0% |
| 5 y | 5-year | -3.59 | -393.0% | -21.58 | +18.0% |
| alltime | all time | -3.59 | -393.0% | -27.46 | +35.5% |
Apellis Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -17.70(-10.2%) |
| 2024 | -19.72(+41.2%) |
| 2023 | -13.97(+63.0%) |
| 2022 | -8.57(+49.8%) |
| Date | Value |
|---|---|
| 2021 | -5.72(-57.1%) |
| 2020 | -13.34(+126.1%) |
| 2019 | -5.90(+23.7%) |
| 2018 | -4.77(-74.4%) |
| 2017 | -18.62 |
FAQ
- What is Apellis Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Apellis Pharmaceuticals?
- What is APLS EV/EBITDA year-to-date change?
- What is Apellis Pharmaceuticals EV/EBITDA year-on-year change?
What is Apellis Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of APLS is -17.70
What is the all time high EV/EBITDA for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high EV/EBITDA is -3.59
What is APLS EV/EBITDA year-to-date change?
Apellis Pharmaceuticals EV/EBITDA has changed by +2.02 (+10.24%) since the beginning of the year
What is Apellis Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, APLS EV/EBITDA has changed by -2.08 (-13.32%)